Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website https://www.journalmc.org

Case Report

Volume 13, Number 5, May 2022, pages 212-218


Clostridium tertium Bacteremia: A Marker of an Underlying Perforated Colonic Diverticular Disease in a Non-Neutropenic Patient With COVID-19

Figure

Figure 1.
Figure 1. Axial images of a contrast-enhanced abdomen and pelvis CT scan revealed (a) extensive free intraperitoneal gas (vertical red arrows) and (b) a thickened sigmoid colon wall (horizontal red arrow) and focal pelvic fluids collection (red star). CT: computed tomography.

Tables

Table 1. Pertinent Laboratory Results on Admission
 
Blood testResultReference range
White cells count (WCC)15,000/mm34,000 - 11,000/mm3
Hemoglobin12.5 g/dL11.0 - 13.0 g/dL
Platelets390,000/mm3150,000 - 500,000/mm3
C-reactive protein (CRP)72 mg/dL1 - 7 mg/dL
Serum creatinine1.7 mg/dL0.6 - 1.1 mg/dL
Serum sodium132 mmol/L133 - 144 mmol/L
Serum potassium3.2 mmol/L3.6 - 5.0 mmol/L
Serum magnesium1.4 mmol/L2.2 - 2.8 mmol/L
Serum lactate3.1 mmol/L0.5 - 2.2 mmol/L
Serum glucose (point-of-care, POCG)350 mg/dL70 - 110 mg/dL
Hemoglobin A1c9.5%< 5.7%
Serum albumin3.1 g/dL3.6 - 5.0 g/dL

 

Table 2. Summary of the Reported Cases of C. tertium Bacteremia as per Literature Review 1990 - 2022 (Including the Presented Case)
 
Authors/publication yearAge (years)/genderClinical presentationPossible risk factorsSubspeciality testing results (if available)/antibiotics instituted to treat C. tertium
CT: computed tomography; C. tertium: Clostridium tertium; COVID-19: coronavirus disease 2019; IBD: inflammatory bowel disease; CD: Crohn’s disease; UC: ulcerative colitis.
Shah et al, 2016 [1]82/femaleNeutropenic fevers/abdominal pain and diarrhea. CT chest with ground glass opacitiesAcute myeloid leukemia (AML) on chemotherapyNo susceptibility testing available. Infection was treated with vancomycin, piperacillin-tazobactam, and ciprofloxacin.
36/femaleNeutropenic fevers/vomiting and diarrheaAML on chemotherapySusceptible to meropenem, piperacillin-tazobactam, penicillin, and metronidazole.
42/femaleNeutropenic fevers/shortness of breath and cough with a nodular infiltrate on chest CTAML on chemotherapySusceptibility results were only provided to metronidazole, the patient was treated empirically with piperacillin-tazobactam and then a 2-week course of clindamycin.
55/maleNeutropenic fevers/lower abdominal pain and diarrheaMyelodysplastic syndrome (MDS) on chemotherapyNo subspeciality testing available. Initially treated with cefepime, followed by vancomycin and piperacillin-tazobactam.
60/maleNeutropenic fevers/shortness of breath and cough and a new perihilar infiltrate on chest X-raysAML on chemotherapyNo susceptibility testing available. Initially treated with cefepime, followed by a 2-week course of vancomycin and metronidazole.
69/maleNeutropenic fevers with ground-glass opacities on chest CT imagingMDS on chemotherapyNo susceptibility testing available. Initially treated with vancomycin and cefepime followed by piperacillin-tazobactam for 2 weeks.
60/maleNeutropenic fevers/fatigueAML on chemotherapyNo susceptibility testing available. Initially treated with ciprofloxacin, then switched to vancomycin and cefepime with cultures results.
Miller et al, 2001 [2]28/maleAbdominal pain, vomiting, and watery diarrhea. CT abdomen with Crohn’s features. Colonoscopy and biopsy confirmed CD. Blood cultures grew C. tertiumCDNo susceptibility testing available. Empirically treated with ciprofloxacin and clindamycin.
Miller et al, 2001 [2]A case series of 32 patients including the above one [2]; 22 patients were males; age ranged widely from 16 to 75 years; 29 patients were neutropenic secondary to chemotherapy. Three non-neutropenic patients were as follows: one had spontaneous bacterial peritonitis (SBP) associated with alcoholic liver cirrhosis, one with CD, and the last one with systemic lupus erythematosus (SLE) treated with high-dose steroids.
Steyaert et al, 1999 [3]65/maleNeutropenic fevers/abdominal pain and diarrheaAML on chemotherapyResistant to ceftazidime, cefepime, and clindamycin; intermediately resistant to penicillin; and susceptible to metronidazole, and vancomycin. Initially treated with ceftazidime and amikacin that were switched to vancomycin following sensitivity results.
55/maleNeutropenic fevers/abdominal pain and diarrheaAML on chemotherapyResistant to ceftazidime, cefepime, and clindamycin; intermediately resistant to penicillin; and susceptible to metronidazole, quinolones, and vancomycin. He was treated with vancomycin.
Wazir et al, 2019 [4]62/maleFatigue and high-grade fevers in a patient with end-stage liver disease. Ascitic fluid analysis revealed SBP. Blood cultures grew C. tertiumAlcoholic liver cirrhosisSusceptible to meropenem, metronidazole, and penicillin. Initial empiric treatment with meropenem and vancomycin then targeted meropenem therapy for 9 days with clearance of C. tertium bacteremia.
Sutton et al, 2017 [5]60/maleWorsening abdominal pain and fevers in the setting of chronic liver disease. Ascitic fluids culture isolated C. tertiumAlcoholic liver cirrhosisSusceptible to meropenem, ciprofloxacin, clindamycin, and vancomycin. Initial empiric treatment with vancomycin and meropenem, then the latter was switched to ciprofloxacin and metronidazole. Repeat cultures were negative.
Chalhoub et al, 2016 [6]54/femalePancolitis progressed to septic shock with acute respiratory distress syndrome (ARDS). Serial blood cultures grew C. tertiumColitis without evidence of IBD. Probable intestinal mucosal injury triggering C. tertium translocationSusceptible to penicillin and vancomycin, resistant to clindamycin. Initially treated imipenem, vancomycin, and ciprofloxacin, the latter switched to ampicillin. The three-antibiotics regime was continued for 3 weeks with clearance of infection.
Gosbell et al, 1996 [7]19/femaleRecurrent neutropenic feversAcute lymphoblastic leukemia (ALL) on chemotherapySusceptible to penicillin, metronidazole, and vancomycin.
57/femaleVomiting and diarrhea in a patient with a known history of UCUCNo susceptibility testing available. C. tertium was isolated in the setting of polymicrobial isolates.
Coleman et al, 1993 [8]15/femaleNeutropenic fevers/abdominal pain and diarrhea. CT abdomen showing enterocolitis of the cecum and right colonALL on chemotherapyNo susceptibility testing available. Initially treated with ceftazidime, metronidazole, and gentamicin regime switched to ciprofloxacin and vancomycin when cultures grew C. tertium. Operative intervention with right hemicolectomy was indicated to control sepsis.
Tappe et al, 2004 [9]51/femalePostoperative fever progressed to septic shock in the setting of ileus post-laparotomy and adhesiolysisParalytic ileus with probable mucosal injury secondary to ileus inducing C. tertium translocationSusceptible to meropenem, imipenem, vancomycin, linezolid, and piperacillin-tazobactam, and resistant to penicillin, cefotaxime, clindamycin, and co-trimoxazole.
Milano et al, 2019 [10]43/maleHigh-grade fevers due to a giant hepatic abscess 4 weeks post-appendectomy for a perforated appendix requiring radiology-guided drainage of the abscessPerforated appendix with polymicrobial peritonitis and bacterial translocation and the recent use of broad-spectrum antibioticsNo susceptibility testing available. C. tertium was isolated in gram-negative polymicrobial blood cultures and the drained hepatic abscess substance. He was treated with radiologically guided hepatic abscess drainage conjugated with piperacillin-tazobactam.
You et al, 2015 [11]44/femaleAcute bronchopneumonia and C. tertium bacteremia identification of using 16S rRNA sequencingSuicidal ingestion of glyphosateSusceptible to penicillin, piperacillin/tazobactam, amoxicillin/clavulanic acid, cephalothin, cefoxitin, imipenem, and vancomycin, but resistance to cefotaxime, ceftazidime, cefepime, gentamicin, clindamycin, and metronidazole.
Ray et al, 2003 [12]58/maleNecrotizing fasciitis of distal lower extremity requiring fasciotomyHistory of non-Hodgkin lymphoma status post-chemotherapy 6 months prior to presentation. Alcoholic liver diseaseNo susceptibility testing available. The patient was treated with imipenem, vancomycin, and metronidazole.
40/maleNecrotizing fasciitis of proximal lower extremity requiring extensive fasciotomyMotor vehicle accident with multiple lower extremities and abdominal injuriesSusceptible to penicillin, ampicillin, vancomycin, and metronidazole.
Salvador et al, 2013 [13]47/maleBreakthrough bacteremia with neutropenic fevers presenting with abdominal painALL on chemotherapySusceptible to metronidazole and moxifloxacin but resistant to ceftriaxone.
Vanderhofstadt et al, 2010 [14]51/maleThe patient was completely asymptomatic. Routine blood cultures prior to the start of induction chemotherapy revealed C. tertium bacteremia.Relapsing AML status post bone marrow transplant who was due to start a new course of induction chemotherapySusceptible to penicillin, amoxicillin-clavulanic, and metronidazole. Resistant to clindamycin.
23/maleNeutropenic fevers without a focus of infectionNon-Hodgkin lymphoma on chemotherapySensitive to amikacin, and ceftazidime but resistant to amoxicillin-clavulanic.
Saad et al, 2022 (present case)66/femaleSeptic shock secondary to C. tertium bacteremia in a critically ill non-neutropenic patient with COVID-19Perforated colonic diverticular disease with bacterial translocationSusceptible to meropenem, metronidazole, and amoxicillin-clavulanic, and piperacillin-tazobactam.